Midkine-A novel player in cardiovascular diseases

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Cytokine Signaling

Background:

• Midkine (MK) is a heparin-binding growth factor with diverse functions, including roles in development, inflammation, and malignancy.
• Recent research highlights MK's involvement in cardiovascular diseases, but its precise impact remains debated.
• Existing studies have focused on MK's roles in reproduction, tissue repair, and cancer, with less emphasis on cardiovascular implications.

Purpose of the Study:

• To comprehensively review the multifaceted roles of Midkine (MK) in cardiovascular biology and diseases.
• To elucidate MK's expression, receptors, signaling pathways, and functions within the vascular system.
• To critically evaluate the current evidence on MK's dualistic (detrimental and favorable) effects in various cardiovascular conditions and explore its diagnostic and therapeutic potential.

Main Methods:

• Literature review synthesizing existing research on Midkine (MK).
• Analysis of MK gene and protein structure, receptors, and signaling pathways.
• Examination of MK expression patterns and functions in cardiovascular physiology and pathology.

Main Results:

• Midkine (MK) exhibits complex and context-dependent effects in cardiovascular diseases, acting as both a protective and detrimental factor.
• Evidence suggests varied expression sources and modes of MK in cardiovascular disease states.
• MK possesses significant diagnostic and therapeutic potential, but its conflicting roles necessitate careful consideration.

Conclusions:

• Midkine (MK)'s role in cardiovascular diseases is intricate, requiring further investigation to harness its therapeutic potential.
• Clarifying the specific conditions under which MK exerts beneficial or harmful effects is crucial for clinical applications.
• MK-based diagnostics and therapies offer promising avenues for managing cardiovascular diseases.